Showing results (281-290 of 405) with videos related to
Sort By:
Pageof 41
Archives of Disease in Childhood. Fetal and Neonatal Edition|January 19, 2017
Skin-to-skin care in preterm infants receiving respiratory support does not lead to physiological instabilityLaila Lorenz, Jennifer A Dawson, Hannah Jones, et al.Respiratory Research|March 17, 2009
Early biomarkers and potential mediators of ventilation-induced lung injury in very preterm lambsMegan J Wallace, Megan E Probyn, Valerie A Zahra, et al.Archives of Disease in Childhood. Fetal and Neonatal Edition|June 11, 2021
Respiratory support after delayed cord clamping: a prospective cohort study of at-risk births at ≥35+0 weeks gestationShiraz Badurdeen, Georgia A Santomartino, Marta Thio, et al.Archives of Disease in Childhood. Fetal and Neonatal Edition|March 4, 2018
Delivery of positive end-expiratory pressure to preterm lambs using common resuscitation devicesMarta Thio, Jennifer A Dawson, Kelly J Crossley, et al.Journal of Applied Physiology (Bethesda, Md. : 1985)|December 21, 2013
Surfactant before the first inflation at birth improves spatial distribution of ventilation and reduces lung injury in preterm lambsDavid G Tingay, Megan J Wallace, Risha Bhatia, et al.The Journal of Pediatrics|November 29, 2008
Ventilation and spontaneous breathing at birth of infants with congenital diaphragmatic herniaArjan B te Pas, C Omar F Kamlin, Jennifer A Dawson, et al.Plos One|November 9, 2013
The administration of 100% oxygen and respiratory drive in very preterm infants at birthJeroen J van Vonderen, Nadia E Narayen, Frans J Walther, et al.Pediatric Research|June 11, 2011
An initial sustained inflation improves the respiratory and cardiovascular transition at birth in preterm lambsKristina S Sobotka, Stuart B Hooper, Beth J Allison, et al.Genome Medicine|October 19, 2013
Analysis of epigenetic changes in survivors of preterm birth reveals the effect of gestational age and evidence for a long term legacyMark N Cruickshank, Alicia Oshlack, Christiane Theda, et al.BMC Pediatrics|June 3, 2016
The N3RO trial: a randomised controlled trial of docosahexaenoic acid to reduce bronchopulmonary dysplasia in preterm infants < 29 weeks' gestationCarmel T Collins, Robert A Gibson, Maria Makrides, et al.Pageof 41